NCCN ALL Response Criteria for Blood and Bone Marrow Relapsed Disease

**Semantic type:** Intellectual Product

**Definition:** Reappearance of blasts in the blood or bone marrow ( greater than 5 percent) or in any extramedullary site after complete remission. (Adapted from NCCN Guidelines, Version 1.2020, February 20, 2020)